Correspondence 0001493152-23-019621 from InspireMD, Inc. (NSPR)
InspireMD, Inc.
Date: May 31, 2023 · CIK: 0001433607 · Accession: 0001493152-23-019621
AI Filing Summary & Sentiment
File numbers found in text: 333-272149
Show Raw Text
CORRESP
1
filename1.htm
InspireMD,
Inc.
4
Menorat Hamaor. St.
Tel
Aviv, Israel 6744832
May
31, 2023
VIA
EDGAR
Securities
and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
DC 20549
RE:
InspireMD,
Inc. (CIK 0001433607)
Registration
Statement No. 333-272149 on Form S-3 (the “Registration Statement”)
Ladies
and Gentlemen:
InspireMD,
Inc. (the “Registrant”) hereby requests acceleration of the effectiveness of the above-referenced Registration Statement
pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), so that it may become effective
on June 1, 2023 at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.
The
undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel,
Greenberg Traurig, LLP, by calling Gary Emmanuel at (212) 801-9337. The Company hereby authorizes Mr. Emmanuel to orally modify or withdraw
this request for acceleration.
Very
truly yours,
INSPIREMD,
INC.
By:
/s/
Craig Shore
Craig Shore
Chief Financial Officer, Chief Administrative Officer, Secretary and Treasurer